7 Spam-Free Article(s) Found
Sort:
Date
Filter:
All
Article Searches
Why Doctor Reddy's (RDY) is a Top Value Stock for the Long-Term https://www.zacks.com/stock/news/2233209/why-doctor-reddy-s-rdy-is-a-top-value-stock-for-the-long-term?cid=CS-ZC-FT-tale_of_the_tape|zacks_education_value_score-2233209 Feb 28, 2024 - Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Why Doctor Reddy's (RDY) is a Top Growth Stock for the Long-Term https://www.zacks.com/stock/news/2230194/why-doctor-reddy-s-rdy-is-a-top-growth-stock-for-the-long-term?cid=CS-ZC-FT-tale_of_the_tape|zacks_education_growth_score-2230194 Feb 22, 2024 - The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Why Doctor Reddy's (RDY) is a Top Momentum Stock for the Long-Term https://www.zacks.com/stock/news/2221076/why-doctor-reddy-s-rdy-is-a-top-momentum-stock-for-the-long-term?cid=CS-ZC-FT-tale_of_the_tape|zacks_education_momentum_score-2221076 Feb 05, 2024 - Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Are You a Growth Investor? This 1 Stock Could Be the Perfect Pick https://www.zacks.com/stock/news/2220309/are-you-a-growth-investor-this-1-stock-could-be-the-perfect-pick?cid=CS-ZC-FT-tale_of_the_tape|zacks_education_growth_score-2220309 Feb 02, 2024 - Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Dr Reddy's Laboratories Ltd (RDY) Q3 2024 Earnings Call Transcript https://seekingalpha.com/article/4666144-dr-reddys-laboratories-ltd-rdy-q3-2024-earnings-call-transcript?source=feed_tag_india Jan 30, 2024 - Dr Reddy's Laboratories Ltd. (NYSE:NYSE:RDY) Q3 2024 Earnings Conference Call January 30, 2024 10:00 AM ETCompany ParticipantsRicha Periwal - IRParag...
3 Generic Drug Stocks to Watch Amid Improving Market Prospects https://www.zacks.com/commentary/2215536/3-generic-drug-stocks-to-watch-amid-improving-market-prospects?cid=CS-ZC-FT-industry_outlook-2215536 Jan 25, 2024 - With the ease in inflationary pressure, the Zacks Medical - Generic Drugs industry is expected to benefit from declining costs. New product launches provide some respite to AMPH, RDY and TEVA.
Journey Medical (DERM) Up on Update for Skin Disease Candidate https://www.zacks.com/stock/news/2194715/journey-medical-derm-up-on-update-for-skin-disease-candidate?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2194715 Dec 07, 2023 - Journey Medical (DERM) plans to submit a new drug application (NDA) to the FDA for DFD-29 to treat rosacea in adults by 2023-end. Stock rises.

Pages: 1

Page 1